EICHOR
● Enrolling By Invitation
Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients
Condition: Pmm2-CDG · Phosphomannomutase 2 Deficiency · Sponsor: Glycomine, Inc.
About this study
The goal of this clinical trial is to provide continued access to GLM101 to treat PMM2-CDG in people who have previously received GLM101 in other trials and learn about the long term effect of GLM101. Participants will complete weekly infusions of GLM101 at the same dose level received in previous trials.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (15)
| University of Minnesota | Minneapolis, Minnesota, United States | — |
| The Icahn School of Medicine at Mount Sinai | New York, New York, United States | — |
| The Children's Hospital of Philadelphia (CHOP) | Philadelphia, Pennsylvania, United States | — |
| Seattle Children's Hospital | Seattle, Washington, United States | — |
| Vseobecna fakultni nemocnice v Praze | Prague, Czechia | — |
| AP-HP Hopital Universitaire Necker-Enfants Malades | Paris, France | — |
| Universitaetsklinikum Münster | Münster, Germany | — |
| Azienda Ospedaliero Universitaria Policlinico G. Rodolico-San Marco - Presidio Ospedaliero G. Rodolico | Catania, Italy | — |
| Azienda Ospedaliero Universitaria Pisana | Pisa, Italy | — |
| Unidade Local de Saúde de Santo António, E.P.E | Porto, Portugal | — |
| Hospital Sant Joan de Déu | Esplugues de Llobregat, Spain | — |
| Hospital Universitario 12 de Octubre - Unidad Pediatrica de Investigacion y Ensayos Clinicos (UPIC) | Madrid, Spain | — |
+ 3 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06657859